AFMID and neoplasm: Sutherland et al. (2014) reported that although KRasG12D was activated in many CC10+ cells that line the bronchi and bronchioles, they rarely observed tumor formation in this area. Thus, CC10+ cells located near the airways appear to be susceptible to the KF, but not to the KP oncogene combination.